title: Prostate cancer: Bone density testing--essential or extraneous?
authors.affiliation: Department of Medicine, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G4-836, Box 358081, Seattle, WA 98109, USA. evanyu@uw.edu
authors.forename: Evan Y
authors.initials: EY
authors.lastname: Yu
mesh_terms: D000367:Age Factors; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects*; D005598:Fractures, Spontaneous / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D020380:Needs Assessment; D010024:Osteoporosis / Q000139:chemically induced* / Q000453:epidemiology; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D018570:Risk Assessment
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal